344 results on '"Ricciarelli, Roberta"'
Search Results
2. Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology
3. Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis
4. Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment
5. Amelioration of Functional and Histopathological Consequences after Spinal Cord Injury through Phosphodiesterase 4D (PDE4D) Inhibition
6. Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-beta pathology
7. cGMP favors the interaction between APP and BACE1 by inhibiting Rab5 GTPase activity
8. New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment
9. A Case of Bilateral Choroidal Effusion after XEN Gel Stent Implantation
10. Tau, tau kinases, and tauopathies: An updated overview
11. Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors
12. SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF
13. A New Bistable Switch Model of Alzheimer’s Disease Pathogenesis
14. Selective inhibition of phosphodiesterase 4D increases tau phosphorylation at Ser214 residue
15. Modulation of cAMP levels by high‐fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression
16. Oxysterol mixture and, in particular, 27-hydroxycholesterol drive M2 polarization of human macrophages
17. Phosphodiesterase 4D: an enzyme to remember
18. Oxidized LDLs as Signaling Molecules
19. Memory enhancers for Alzheimer's disease: focus on cGMP
20. PDE4D inhibitors: A potential strategy for the treatment of memory impairment?
21. Alternative splicing and gene polymorphism of the human TAP3/SEC14L4 gene
22. A novel mechanism for cyclic adenosine monophosphate–mediated memory formation: Role of amyloid beta
23. Memory Enhancers for Alzheimer’s Dementia: Focus on cGMP
24. Protein kinase G phosphorylates the Alzheimer's disease‐associated tau protein at distinct Ser/Thr sites
25. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits
26. Specific cellular responses to [alpha]-tocopherol
27. Reduction of senescence‐associated beta‐galactosidase activity by vitamin E in human fibroblasts depends on subjects’ age and cell passage number
28. Evaluating the Correlation between Alzheimer's Amyloid-β Peptides and Glaucoma in Human Aqueous Humor
29. Aqueous humor Beta42-amyloid and total protein concentration in glaucomatous patients
30. Troglitazone, a peroxisome proliferator-activated receptor-γ agonist, decreases tau phosphorylation in CHOtau4R cells
31. CD36 overexpression in ritonavir-treated THP-1 cells is reversed by α-tocopherol
32. Microarray Analysis in Alzheimerʼs Disease and Normal Aging
33. CD36 overexpression in human brain correlates with β-amyloid deposition but not with Alzheimerʼs disease
34. Cloning of novel human SEC14p-like proteins: ligand binding and functional properties
35. Isoelectric Point Mobility Shift Assay for Rapid Screening of Charged and Uncharged Ligands Bound to Proteins
36. Nonantioxidant Functions of α-Tocopherol in Smooth Muscle Cells
37. Specific Cellular Responses to α-Tocopherol
38. cAMP, cGMP and Amyloid β: Three Ideal Partners for Memory Formation
39. Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus
40. Age-dependent increase of collagenase expression can be reduced by α-tocopherol via protein kinase C inhibition
41. Vitamin E mediated response of smooth muscle cell to oxidant stress
42. Amyloid Beta and the Brain: Where Are We Now?
43. Glucagon-Like Peptide 1, Neuroprotection and Neurodegenerative Disorders
44. Investigating the amyloid-beta enhancing effect of cGMP in neuro2a cells
45. The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
46. Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory
47. Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease
48. A NOVEL CAMP/PKA/APP/ABeta PATHWAY MODULATES HIPPOCAMPAL LTP
49. cAMP-induced Aβ production and its role in the expression of LTP
50. Evidence for a physiological role of Abeta in memory formation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.